Health Sector Down As Report of Industry Price Collusion Surfaces

U.S. stocks were down slightly on Thursday as the S&P 500 maintains its longest losing streak since the financial crisis in 2008. The healthcare sector fell the most at 1.10%.

Two of the most active players, Teva Pharmaceutical Industries  (TEVA) and Pfizer  (PFE) , drove down the sector. Shares of Teva Pharmaceutical Industries fell almost 10% to $39.20 after Bloomberg reported that the Israel-based company has received subpoenas for its suspected role in price collusion with other generic pharmaceutical companies.

New York-based drug-maker Pfizer reported worse-than-expected third-quarter profit of 61 cents a share on Tuesday. It also announced a surprising end to the late-stage development of an experimental cholesterol-lowering drug. Shares of Pfizer decreased 2.42% to $29.89 today.

The Dow Jones Industrial Average lost 29 points, or 0.16%, down to 17,930. The S&P 500 index fell 9 points, or 0.44%, to 2,088, and the Nasdaq composite declined about 47 points, or 0.92%, to 5,058.

The biggest losers of the day were Achillion Pharmaceuticals  (ACHN) , Pacific Biosciences of California (PACB) , Impax Laboratories  (IPXL) , Akorn  (AKRX) and Insmed  (INSM) . 

New Haven, CT.-based biopharmaceutical company Achillion Pharmaceuticals reported a net loss of $20.7 million, or 15 cents per share, compared with net income of $26.3 million (19 per share) for the third quarter of 2015 in its third quarter earnings release today. Shares of Achillion tumbled almost 29% to $4.32 by the closing bell.

If you liked this article you might like

The 6 Medications Being Used to Tackle the Opioid Epidemic

Dow, S&P 500 Set New Records as Fed Moves to Unwind Balance Sheet

Stocks In Negative Territory as Chances for December Hike Surge

The Wait for 'Milestone' Fed Meeting Keeps Stocks in Flux